As the potential to drug the RNA increases, a plethora of previously un-druggable targets are opening up. Curated with the insights from those leading the push in Pharma, Biotech & Academia, the RNA Targeted Drug discovery Summit is devoted to optimizing the process of discovering small molecules that bind specifically to quality RNA targets and translating these into clinically effective therapies. Meet Dietmar Wolf in Boston!